City Research Online

Items where Author is "Wedderburn, L. R."

Up a level
Group by: Type | No Grouping
Number of items: 11.

Flood, C., Hirani, S. ORCID: 0000-0002-1577-8806, Mulligan, K. ORCID: 0000-0002-6003-3029 , Taylor, J., Harris, S., Wedderburn, L. R. & Newman, S. (2024). Economic evaluation of a trial exploring the effects of a web-based support tool for parents of children with Juvenile Idiopathic Arthritis. Rheumatology, doi: 10.1093/rheumatology/keae188

Mulligan, K. ORCID: 0000-0002-6003-3029, Hirani, S. P. ORCID: 0000-0002-1577-8806, Harris, S. , Taylor, J., Wedderburn, L. R. & Newman, S. (2022). The Effects of a Web-based Tool for Parents of Children with Juvenile Idiopathic Arthritis: Randomised Controlled Trial. Journal of Medical Internet Research, 24(5), article number e29787. doi: 10.2196/29787

Livermore, P., Gibson, F., Mulligan, K. ORCID: 0000-0002-6003-3029 , Wedderburn, L. R., McCann, L. J. & Gray, S. (2021). Mapping the current psychology provision for children and young people with Juvenile Dermatomyositis. Rheumatology Advances in Practice, 5(3), article number rkab062. doi: 10.1093/rap/rkab062

Mulligan, K. ORCID: 0000-0002-6003-3029, Hirani, S. P. ORCID: 0000-0002-1577-8806, Clarke, S. ORCID: 0000-0003-0496-0597 , Evans, N. R., Flood, C., Taylor, J.E., Wedderburn, L. R., Newmanon, S. & Grp, WebParC Investigator (2020). Website for parents of children with juvenile idiopathic arthritis reduces parenting stress. Annals of the Rheumatic Diseases (ARD), 79, article number 1295. doi: 10.1136/annrheumdis-2020-eular.3510

Whitelaw, P., Mulligan, K. ORCID: 0000-0002-6003-3029, Wedderburn, L. R. , Hirani, S. P. ORCID: 0000-0002-1577-8806 & Newman, S. P. ORCID: 0000-0001-6712-6079 (2017). Evaluation of a Website for Parents of Children with Juvenile Idiopathic Arthritis (JIA) – WebParC. RHEUMATOLOGY, 56(S7), article number kex390.048. doi: 10.1093/rheumatology/kex390.048

Mulligan, K., Wedderburn, L. R. & Newman, S. P. (2015). The experience of taking methotrexate for juvenile idiopathic arthritis: results of a cross-sectional survey with children and young people. Pediatric Rheumatology, 13(1), article number 58. doi: 10.1186/s12969-015-0052-6

Cobb, J., Cule, E., Moncrieffe, H. , Hinks, A., Ursu, S., Patrick, F., Kassoumeri, L., Flynn, E., Bulatović, M., Wulffraat, N., van Zelst, B., de Jonge, R., Bohm, M., Dolezalova, P., Hirani, S. P., Newman, S. P., Whitworth, P., Southwood, T., De Iorio, M., Childhood Arthritis Response to Medication Study (CHARMS), ., Childhood Arthritis Prospective Study (CAPS), ., BSPAR study group, ., Wedderburn, L. R. & Thomson, W. (2014). Genome-wide data reveal novel genes for methotrexate response in a large cohort of juvenile idiopathic arthritis cases. The Pharmacogenomics Journal, 14(4), pp. 356-364. doi: 10.1038/tpj.2014.3

Mulligan, K., Kassoumeri, L., Etheridge, A. , Moncrieffe, H., Wedderburn, L. R. & Newman, S. P. (2013). Mothers' reports of the difficulties that their children experience in taking methotrexate for Juvenile Idiopathic Arthritis and how these impact on quality of life. Pediatric Rheumatology, 11(1), article number 23. doi: 10.1186/1546-0096-11-23

Wickwar, S., Buerkle, K., McBain, H. B. , Kassoumeri, L., Ciciriello, S., Osborne, R., Wedderburn, L. R. & Newman, S. P. (2013). Adaptation of the methotrexate in rheumatoid arthritis knowledge questionnaire (MiRAK) for use with parents of children with juvenile idiopathic arthritis (JIA). Paediatric Rheumatology, 11(1), article number 27. doi: 10.1186/1546-0096-11-27

Buerkle, K., Mulligan, K., Hirani, S. P. , Kassoumeri, L., Etheridge, A., Wedderburn, L. R. & Newman, S. P. (2011). The Impact of Response to MTX on the Illness and Treatment Beliefs of Parents of Children with JIA. RHEUMATOLOGY, 50(Supp 3), article number 131.

Mulligan, K., Etheridge, A., Kassoumeri, L. , Wedderburn, L. R. & Newman, S. P. (2009). Do Mothers and Fathers Hold Similar Views About Their Child's Arthritis?. Arthritis Care and Research, 61(12), pp. 1712-1718. doi: 10.1002/art.25008

This list was generated on Fri Mar 29 07:32:04 2024 UTC.